Position in MRK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,078,217
+$402,968 QoQ
Shares Held
23,955
+7.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.41%
of 13F equity value
Holder Rank
#1,323
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Capital Asset Advisory Services LLC holds $29,712,872 across 11 Drug Manufacturers - General names. MRK ranks #5 (10.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
26,233 | $6,662,395 | |
| 2 | LLY |
ELI LILLY & Co
|
4,985 | $5,979,159 | |
| 3 | ABBV |
AbbVie Inc.
|
22,814 | $5,740,914 | |
| 4 | PFE |
Pfizer Inc
|
138,613 | $3,337,801 | |
| 5 | MRK |
Merck & Co., Inc.
This page
|
23,955 | $3,078,217 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
46,813 | $2,697,365 | |
| 7 | AMGN |
Amgen Inc
|
1,448 | $524,349 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
4,064 | $513,445 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,078,217 | 23,955 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,675,249 | 22,240 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $2,386,981 | 22,677 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $1,868,617 | 22,264 | Shares | Sole | 2025-10-02 | |
| 2025-06-30 | $1,563,330 | 19,749 | Shares | Sole | 2025-07-07 | |
| 2025-03-31 | $1,733,175 | 19,309 | Shares | Sole | 2025-04-09 | |
| 2024-12-31 | $2,099,326 | 21,103 | Shares | Sole | 2025-01-22 | |
| 2024-09-30 | $2,334,225 | 20,555 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $2,603,018 | 21,026 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $3,505,779 | 26,569 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $2,709,910 | 24,857 | Shares | Sole | 2024-01-09 | |
| 2023-09-30 | $2,518,877 | 24,467 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $2,604,583 | 22,572 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $2,306,322 | 21,678 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $2,286,790 | 20,611 | Shares | Sole | 2023-03-08 | |
| 2022-09-30 | $1,751,766 | 20,341 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,772,527 | 19,442 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $1,412,408 | 17,214 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $1,258,965 | 16,427 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $882,242 | 11,746 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $957,193 | 12,308 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $1,017,819 | 13,203 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $949,942 | 11,613 | Shares | Sole | 2021-03-02 | |
| 2020-09-30 | $812,329 | 9,793 | Shares | Sole | 2020-11-18 | |
| 2020-06-30 | $732,006 | 9,466 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $621,598 | 8,079 | Shares | Sole | 2020-05-18 | |
| No filing history on record for this holder in this stock. | ||||||